KALV

Conviction 22HealthcareScan · Thu, Jun 25, 2026

KALV$0.0000-100.00%

ResistanceSupportVol 14Insider sell

Vol MA14 2.52M

Mar 13Mar 31Apr 20May 6May 26Jun 11

KalVista Pharmaceuticals, Inc.Biotechnology

Price0.0000

Change-100.00%

Gap-100.00%

Rel volume0.00×

Avg volume3.24M

Avg $ vol87.06M

SMA 2025.52

SMA 5023.61

SMA 20016.78

Price vs 50-100.00%

Price vs 200-100.00%

MA stackmixed

50/200 cross—

Supertrenddown · 8.44

RSI (14)5

MACD hist-1.95

MACD cross—

Stoch %K / %D0 / 66

ADX (14)59

+DI / −DI4 / 91

RSI divergenceBearish

MACD divergenceBearish

ATR %—

ADR %0.17%

52w high27.00

52w low0.0000

From 52w high-100.00%

Above 52w low—

New 52w highNo

SqueezeFired

Bollinger width91.78%

%B-0.59

Donchian pos0.00%

Donchian high27.00

Donchian low0.0000

AVWAP (52w high)26.99

vs AVWAP high-100.00%

AVWAP (52w low)—

vs AVWAP low—

OBV trendUp

Chaikin MF (20)-0.00

Today vs 20d0.00×

Avg vol (14d)2.52M

Avg vol (20d)3.24M

Avg $ vol (20d)87.06M

Market cap0

RS 3m (vs SPY)-110.76%

RS 6m (vs SPY)-108.01%

RS line new highNo

Trend template3/8

Technical rank—

1 week-100.00%

1 month-100.00%

3 months-100.00%

6 months-100.00%

1 year-100.00%

YTD-100.00%

P/E0.00

P/B0.00

P/S0.00

P/FCF0.00

EPS-3.69

Div yield—

ROE933.46%

ROA-55.77%

Debt/Eq-8.76

Current5.17

EV/EBITDA0.22

Gross margin—

Net margin—

Rev growth0.00%

EPS growth-44.85%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-41.56M

Revenue40.86M

Net income-23.49M

Gross profit—

Free cash flow-153.34M

IndustryBiotechnology

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float34.75M

Float %68.7%

Short interest6.84M

Days to cover2.0d

Short volume—

Squeeze score62 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction22 / 100

Pattern quality—

Tech rank—

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance26.89

Support18.66

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KALV

All disclosures →

No recent disclosed trades by Congress in KALV. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KALV · 4 buys · 6 sells

Insider	Side	Shares	Value	Traded	Filed
Yea Christopher CHIEF DEVELOPMENT OFFICER · Employee Stock Option (Right to Buy) · 2026-05-27	Exercise	33.8K	$0	2026-05-27	2026-05-29
Yea Christopher CHIEF DEVELOPMENT OFFICER · Common Stock · 2026-05-27	Exercise	33.8K	$239K	2026-05-27	2026-05-29
Yea Christopher CHIEF DEVELOPMENT OFFICER · Common Stock · 2026-05-27	Sell	33.8K	$905K	2026-05-27	2026-05-29
Sweeny Nicole Chief Commercial Officer · Common Stock · 2026-05-26	Sell	1.49K	$40K	2026-05-26	2026-05-27
Yea Christopher CHIEF DEVELOPMENT OFFICER · Common Stock · 2026-05-26	Sell	1.97K	$53K	2026-05-26	2026-05-27
Audhya Paul K. CHIEF MEDICAL OFFICER · Common Stock · 2026-05-26	Sell	2.24K	$60K	2026-05-26	2026-05-27
Yea Christopher CHIEF DEVELOPMENT OFFICER · Restricted Stock Unit · 2026-05-22	Exercise	3.13K	$0	2026-05-22	2026-05-27
Sweeny Nicole Chief Commercial Officer · Common Stock · 2026-05-22	Exercise	5K	—	2026-05-22	2026-05-27
Yea Christopher CHIEF DEVELOPMENT OFFICER · Common Stock · 2026-05-22	Exercise	3.13K	—	2026-05-22	2026-05-27
Audhya Paul K. CHIEF MEDICAL OFFICER · Common Stock · 2026-05-22	Exercise	5K	—	2026-05-22	2026-05-27

SEC filings

EDGAR filings in KALV · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.